Soft tissue sarcomas are a rare group of cancers that develop in soft tissue. They can develop almost anywhere in your body, including in your hip, thigh, and groin. Soft tissue sarcomas are rare ...
Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the extremity, a randomized trial showed. In patients with mostly undifferentiated ...
A triple-drug regimen combining two immunotherapy agents with radiation before surgery appears to activate immune defenses ...
Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy. The study involved 52 patients with high-grade STS, with a median ...
Causes of Soft Tissue Sarcoma:The exact soft tissue sarcoma causes remain unclear, but several risk factors have been identified. These include a family history of inherited conditions such as ...
This article first appeared with Targeted Oncology ™. An orphan drug designation (ODD) was granted by the FDA to elraglusib for the treatment of patients with soft tissue sarcoma (STS). 1 Currently, a ...
Soft tissue sarcomas are rare solid tumors that are being increasingly classified and treated by subtype. Approximately 12,020 people will be diagnosed with a soft tissue sarcoma in the United States ...
A doctor may use an ultrasound scan as one of the first tests to diagnose and assess a soft tissue sarcoma. An ultrasound can help doctors determine the nature of the lump and plan the most effective ...
A phase II study of an oncolytic herpes simplex virus 2 and an anti-PD-1 antibody in patients with advanced sarcoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...
Soft tissue sarcoma (STS) is a form of cancer that can affect adults and children. However, it is rare, affecting only about 1% of the population. It is possible to cure STS with early detection and ...
A recent analysis reveals that the incidence rates of soft tissue sarcomas - cancers in muscle, fat, blood vessels, nerves, and tendons - are lower in young U.S. active-duty military servicemen ...